by Rachel Montague | Dec 17, 2021 | Industry insights
Written by Amy Crompton, Systematic Review Analyst Previously, we discussed the use of real-world evidence (RWE) in the reimbursement assessment of medical devices. In this latest blog, we present an overview of the RWE framework created by the National Institute for...
by Rachel Montague | Dec 13, 2021 | Industry insights
Written by Emma Lones, Medical Writer What are rare diseases? In the European Union, a rare disease is defined as a disorder affecting ≤5 in 10,000 persons (1). Using this definition, the global population prevalence of rare diseases is estimated to be between...
by Rachel Montague | Nov 30, 2021 | Industry insights
Amy Crompton (Systematic Review Analyst) and Tom Macmillan (Consultant – Systematic Review) Hierarchy of evidence Different study designs are often ranked in a hierarchy of evidence based on their validity and robustness. Randomised controlled trials...
by Rachel Montague | May 6, 2021 | Industry insights
Amy Cromptom (Systematic Review Analyst) and Tom Macmillan (Consultant – Systematic Review) This blog post follows on from ‘Improving your search strategy: Randomised controlled trial filters’. Electronic database searches can be run on multiple platforms. This...
by Rachel Montague | Apr 19, 2021 | Industry insights
Written by Daisy Stewart (Systematic Review Analyst) and Tom Macmillan (Consultant – Systematic Review) A search filter is a pre-written search strategy (string of search terms) that is designed to retrieve studies with a particular methodology or focus from a...
by Rachel Montague | Apr 16, 2021 | Industry insights
Written by Pip White, Senior Medical Writer The global value dossier (GVD) is an essential tool used to internally align the global strategy and externally communicate the value of a product. The GVD presents evidence-based messaging to convey the product value...
